The company will develop and commercialize intellectual property for novel graphene and nanomaterial-based products with a focus on healthcare solutions in the areas of prevention, detection and treatment, and will produce pilot-scale antimicrobial coatings for application to other materials and products, as well as spunbond polypropylene nonwovens used in the manufacture of surgical masks.